Results 201 to 210 of about 542,433 (374)

Inextricable association of connective tissue disease with B‑cell lymphoma (Review). [PDF]

Mol Clin Oncol
Ruan JS, Xu S, Shan NN.
europepmc   +1 more source

A potential tumor suppressor role of PLK2 in glioblastoma

FEBS Open Bio, Volume 15, Issue 5, Page 856-866, May 2025.
PLK2 was consistently downregulated in GBM tissues. Overexpression of PLK2 in GBM cell lines U87MG and U251 reduced their tumorigenic potential and enhanced cell cycle arrest and apoptosis. Suggesting that PLK2 overexpression could potentially be leveraged as a therapeutic strategy to inhibit tumor progression and enhance apoptosis, providing new ...
Xiangping Xia, Peirui Wang, Hua Xiao, Qishan Ran, Yan Li, Shengtao Yao   +5 more
wiley   +1 more source

Physiologic relevance of the transpulmonary metabolome in connective tissue disease-associated pulmonary vascular disease. [PDF]

JCI Insight
Lee MH, Menezes TCF, Reisz JA, Cendali FI, Ferreira EVM, Ota-Arakaki JS, Sperandio PA, Kumar R, Mickael C, Ieong MM, Santos JL, Duarte ACB, Fonseca Balladares DC, Nolan K, Tuder RM, Hassoun PM, D'Alessandro A, Oliveira RKF, Graham BB.   +18 more
europepmc   +1 more source

Localization of nRNP antigen in mammalian cells stained with peroxidase-labelled IgG fraction of anti-nRNP antibody obtained from a patient with mixed connective tissue disease (MCTD).

, 1987
Koichi Saito, Keiichi Sagawa, Tomoe Nishimaki, Takao MORITO, KIROSHI YOSHIDA, Reiji Kasukawa   +5 more
openalex   +2 more sources

Bioengineering facets of the tumor microenvironment in 3D tumor models: insights into cellular, biophysical and biochemical interactions

FEBS Open Bio, EarlyView.
The tumor microenvironment is a dynamic, multifaceted complex system of interdependent cellular, biochemical, and biophysical components. Three‐dimensional in vitro models of the tumor microenvironment enable a better understanding of these interactions and their impact on cancer progression and therapeutic resistance.
Salma T. Rafik, Deniz Bakkalci, Alexander J. MacRobert, Umber Cheema   +3 more
wiley   +1 more source

Differences in Tolerability of Antifibrotic Agents Between Connective Tissue Disease-Associated and Non-connective Tissue Disease-Associated Interstitial Lung Disease. [PDF]

Cureus
Nakamura T, Jinta T, Kitamura A, Tanaka M, So C, Ro S, Imai R, Okafuji K, Tomishima Y, Nishimura N.   +9 more
europepmc   +1 more source

Dermoscopic features of connective tissue disease

Przegląd Dermatologiczny
Sopiko Liluashvili, Salome Pataraia, Tina Kituashvili   +2 more
doaj   +1 more source

Adenosine A3 receptor antagonists as anti‐tumor treatment in human prostate cancer: an in vitro study

FEBS Open Bio, EarlyView.
The A3 adenosine receptors (A3ARs) are overexpressed in prostate cancer. AR 292 and AR 357, as A3AR antagonists, are capable of blocking proliferation, modulating the expression of drug transporter genes involved in chemoresistance, ferroptosis, and the hypoxia response, and inducing cell death.
Maria Beatrice Morelli, Andrea Spinaci, Cui Chang, Rosaria Volpini, Catia Lambertucci, Matteo Landriscina, Vincenza Conteduca, Consuelo Amantini, Cristina Aguzzi, Laura Zeppa, Martina Giangrossi, Laura Soverchia, Matteo Santoni, Massimo Nabissi, Giorgio Santoni, Carlo Polidori   +15 more
wiley   +1 more source

A Case of Undifferentiated Connective Tissue Disease with Bilateral Auricular Polychondritis Manifestations: A Rare Clinical Association. [PDF]

Am J Case Rep
Nigro A, Santarcangelo P, Bonelli A, Digregorio S, Nicoletti G.   +4 more
europepmc   +1 more source

Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynauds's phenomenon with and without an underlying connective tissue disease [PDF]

, 1990
Henk Groen, G. Wichers, E. J. ter Borg, Thomas W. van der Mark, A. A. Wouda, Cees G. M. Kallenberg   +5 more
openalex   +1 more source